Non Transplant Treatments for MDS & Secondary AML

Video

Dr. Toyosi Odenike, University of Chicago and Dr. Eric Padron, H. Lee Moffitt Cancer Center, discuss the highlights of their session on Non-Transplant Treatments for Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (AML) at the 2018 AAMDSIF International Bone Marrow Failure Disease Scientific Symposium, March 2018.

Dr. Toyosi Odenike, University of Chicago and Dr. Eric Padron, H. Lee Moffitt Cancer Center, discuss the highlights of their session on Non-Transplant Treatments for Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (AML) at the 2018 AAMDSIF International Bone Marrow Failure Disease Scientific Symposium, March 2018.

Related Videos
Related Content
Reblozyl is a ‘Better First-Line Therapy’ for Anemia in MDS Subset

Reblozyl is a ‘Better First-Line Therapy’ for Anemia in MDS Subset

September 19th 2023
Article

Reblozyl for anemia in patients with an MDS subset demonstrated positive effects, compared with previous treatments, according to an MDS expert.

Read More

AAMDS Upcoming Events: March 2022

AAMDS Upcoming Events: March 2022

February 16th 2022
Article

AAMDSIF hosts Patient & Family Conferences around the United States each year.

Read More

AAMDS Upcoming October 2021 Events

AAMDS Upcoming October 2021 Events

September 15th 2021
Article

Learn more about upcoming October events from the Aplastic Anemia and MDS International Foundation.

Read More

AAMDS Upcoming Events

AAMDS Upcoming Events

August 31st 2021
Article

Learn more about upcoming events from the Aplastic Anemia and MDS International Foundation.

Read More

Site Logo

AAMDSIF Upcoming Webinars: August 2019

July 22nd 2019
Article

The Aplastic Anemia and MDS International Foundation presents webinars for patients and their loved ones at no charge to participants.

Read More

Site Logo

AAMDSIF Presents First Lifetime Achievement in Science Award to Dr. Mary Horowitz

June 25th 2019
Article

The Aplastic Anemia & MDS International Foundation presented its first Lifetime Achievement in Science Award to Mary Horowitz, MD, MS at the Foundation’s 35th Anniversary Luncheon and Awards Program on May 18, 2019. Dr. Horowitz was honored for the significant impact her work has had on stem cell transplant and hematologic malignancy practice worldwide.

Read More